Dr. Baughman’s knowledge and extensive experience in preclinical and clinical PK/PD, bioanalysis, and ADME of both small and large molecules will further strengthen NDA Partners’ clinical pharmacology and pharmacometrics expertise to support our clients’ product development programs.
ROCHELLE, Va. (PRWEB)
December 16, 2021
NDA Partners Vice President of Operations, Eric Fish, announced today that Sharon Baughman, PhD, an experienced biotechnology and pharmaceutical scientist executive, has joined the firm as an Expert Consultant. Dr. Baughman has more than 20 years of experience in the biotechnology and pharmaceutical industry in preclinical and clinical pharmacokinetics, pharmacodynamics, bioanalysis, and ADME of protein and small molecule entities. She served in Director-level positions at Amgen and Genentech in Research Quality and Compliance, and Pharmacokinetics & Drug Metabolism.
Throughout her career, Dr. Baughman led cross-functional teams in support of research and development of novel therapeutics in the areas of oncology, cardiology, inflammation, endocrinology, neurology, metabolism, and bone. She also has extensive experience performing due diligence to assess molecules for in-license, in addition to experience with clinical study design and program development for biosimilars, high quality and timely delivery of regulatory documents, including INDs, BLAs, CTXs and CTDs, and effective interactions with FDA and other regulatory bodies.
According to Dr. Carl Peck, Manager of NDA Partners’ drug development practice, “Dr. Baughman’s knowledge and extensive experience in preclinical and clinical pharmacokinetics, pharmacodynamics, bioanalysis, and ADME of both small and large molecules will further strengthen NDA Partners’ clinical pharmacology and pharmacometrics expertise to support our clients’ product development programs. We are pleased to welcome her to our team of Expert Consultants.”
Dr. Baughman received her doctoral degree in physical organic chemistry from Rice University and bachelor’s degree in chemistry from the University of New Orleans.
About NDA Partners
NDA Partners, a ProPharma Group company, is a life sciences management consulting and contract development organization focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.
Contact
Eric Fish, Vice President, Operations
Office: 540-738-2550
FishEric@ndapartners.com
Share article on social media or email: